Effect of SGLT2 inhibition on glucosuria during a hyperglycemic clamp in HNF1A-MODY (MODY3) and type 2 diabetes
Maagensen H, Jensen JS, Høyerup SO, et al.
Diabetes Care. 2025:dc250737.
Leggi
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Maagensen H, Jensen JS, Høyerup SO, et al.
Diabetes Care. 2025:dc250737.
Leggi
Beese SE, Price MJ, Tomlinson C, et al.
BMC Med. 2025;23(1):351.
Leggi
Vähäkangas E, Saarimäki-Vire J, Montaser H, et al.
Diabetologia. Pub. online 2 Jul 2025.
Leggi
Kermansaravi M, Omar I, Finer N, et al.
BMC Endocr Disord. 2025;25(1):151.
Leggi
Vallivaara HL, Leppänen HA, Mustonen J, et al.
Diabetes Obes Metab. Pub. online 27 Jun 2025.
Leggi
Franc S, Charpentier G
Diabetes Obes Metab. Pub. online 25 Jun 2025.
Leggi
DeFronzo RA, Fonseca V, Aroda VR, et al.
Diabetes Care. Pub. online 23 Jun 2025.
Leggi
Rosenstock J, Bailey TS, Connery L, et al.
N Engl J Med. Pub. online 22 Jun 2025.
Leggi
Reichman TW, Markmann JF, Odorico J, et al.
N Engl J Med. Pub. online 20 Jun 2025.
Leggi
Kalyani RR, Neumiller JJ, Maruthur NM, Wexler DJ
JAMA. Pub. online 23 Jun 2025.
Leggi